Buy Eiger BioPharmaceuticals Stock | EIGR Stock Price & Latest News | Public.com
EIGR

Eiger BioPharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Eiger BioPharmaceuticals (EIGR) stock trends here

    About EIGR

    Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jef...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.39
    -0.58
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.49

    Actual EPS
    Q2 2021

    Stats

    Market Cap$284,77M
    Volume89,49k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$13.99
    1 Year Low$6.76
    Open$8.54
    High$8.55
    Low$8.37

    Buy any stock with any amount of money.

    Download the App
    Download the app